baber/WOPTO huggingface dataset:
Patent AU-713466-B2 (AU)
Title: Carbohydrate-modified cytostatics
Inventor: LERCHEN HANS-GEORG
IPC: A61K31/02
Filed: 1996-03-22
Granted: 1999-12-02
Abstract: The invention relates to cytostatics which, by modification with sugar, are tumor-specific. Suitable spacers ensure serum stability and at the same time an intracellular action.
Patent AU-764906-B2 (AU)
Title: Contact lens and ophthalmic solutions
Inventor: BRUIJN CHRIS DE
IPC: C11D7/44
Filed: 1999-08-05
Granted: 2003-09-04
Abstract: Provided is an ophthalmic solution comprising 10 - 10,000 parts per million of a naturally-occurring microbicidal compound selected from allicin, aucubin, berberine, bilberry extract, caffeic acid, chlorogenic acid, echinacea extract, ferulic acid, hydrastine, lipoic acid, naringin, oleuropein, proanthocyanidins, quercetin and rutin. The solution may further comprise 1 - 100 parts per million of benzyldimethyl ä2-Ä2-(p-1,1,3,3-tetramethylbutylphenoxy) ethoxyÜethylü ammonium chloride. <??>It has been found that the solution reduces the number and variety of pathogenic microorganisms that may infect rigid gas permeable or soft contact lenses.
Patent AU-624947-B2 (AU)
Title: Filter element for separating dusts from gases
Inventor: WEBER EKKEHARD
IPC: B01D39/20
Filed: 1990-05-09
Granted: 1992-06-25
Abstract: A filter element is disclosed which serves to separate dusts from gases or air and consists of metals, alloys or plastics. The element is thin-walled and sheetlike, has a wall thickness of 0.05 to 2 mm and has a large number of regularly arranged holes, which have any of various shapes and sizes and have a non-circular cross-section and a hydraulic diameter of 0.01 to 1 mm. In that filter element the area which is occupied by the holes is 3 to 25% of the front surface area of the filter element.
Patent AU-620253-B2 (AU)
Title: Process for producing small particles of biologically active molecules
Inventor: BROWN LARRY R
IPC: A61K9/16
Filed: 1990-05-01
Granted: 1992-02-13
Abstract: Small diameter particles of biologically active molecules are produced by atomizing solutions of the molecules through a nozzle into very cold liquified gases, which immediately freeze the atomized droplets. The resulting frozen particles having diameters of approximately 10 to 90 micrometers are lyophilized to produce porous particles, suspended in a non-solvent for the molecules, and exposed to ultrasonic energy or homogenization to produce particles having diameters of 0.1 to 10 micrometers with greater than 70 to 95% of the initial biological activity of the molecules in solution.
Patent AU-539693-B2 (AU)
Title: Controlling flow of liquid metal
Inventor: BARZANTNY JOACHIM
IPC: H02K44/06
Filed: 1980-06-13
Granted: 1984-10-11
Abstract: Device for controlling a liquid metal flow in a tube having a prismatic cross section including a plurality of comb-like slotted magnet cores grouped about the periphery of the tube and extending parallel to the flow direction of the liquid metal, electromagnetic coils respectively connected to one of the phases of a polyphase alternating current and mounted respectively on teeth of the plurality of comb-like magnet cores, n.x of the coils of which n equals an optional whole number and x equals the number of a-c phases being mounted on each of the magnet cores, the magnet cores being disposed in planes extending at an angle other than 90 DEG  to the surface of the tube.
Patent AU-671721-B2 (AU)
Title: Tgf-beta formulation for inducing bone growth
Inventor: AMMANN ARTHUR J
IPC: A61L27/22
Filed: 1994-01-11
Granted: 1996-09-05
Abstract: A formulation for transforming growth factor- beta  is provided that contains tricalcium phosphate, preferably in the form of particles such as granules. The formulation optionally contains a polymer such as amylopectin for enhancing consistency of the formulation.
Patent AU-761507-B2 (AU)
Title: Vehicle undercarriage
Inventor: WACHAUER OSKAR
IPC: B60G9/04
Filed: 1999-10-05
Granted: 2003-06-05
Abstract: The invention relates to a vehicle undercarriage (1) or chassis for a vehicle, especially for a four-wheeled, driven vehicle for transporting at least one person. At least one main frame (2) is provided, said main frame (2) being configured as an arrangement of closed hollow profiles. The main frame (2) also has diametrically opposed torsion springs (4), whose axis of revolution runs crosswise in relation to the direction of travel. The torsion springs (4) are connected to side hollow profiles (3) of the main frame (2) with gusset plates (5). A flexurally resistant connecting pin (7) is provided on the torsion springs (4) with an oscillating lever (6), the connecting pin having a mounting (8) at its ends for the wheels.
Patent AU-725602-B2 (AU)
Title: Oxidant scavengers
Inventor: TROVA MICHAEL P
IPC: A61K31/40
Filed: 1996-06-07
Granted: 2000-10-12
Abstract: The present invention relates, in general, to a method of modulating physiological and pathological processes and, in particular, to a method of modulating intra- and extracellular levels of oxidants and thereby processes in which such oxidants are a participant. The invention also relates to compounds and compositions suitable for use in such methods.
Patent AU-652724-B2 (AU)
Title: Peptides from GTPase-activating protein (GAP) and diagnostic and therapeutic use thereof
Inventor: MCCORMICK FRANCIS P
IPC: G01N33/566
Filed: 1990-08-20
Granted: 1994-09-08
Abstract: Peptides, that inhibit GAP stimulated ras p21 hydrolysis of GTP; peptides that mediate dissociation of GDP from ras p21-GTP complex; and antibodies to the peptides are described. These peptides are useful as cancer diagnostics and therapeutics, particularly to detect cancer cells with an over expression of normal or oncogenic ras p21 protein and to treat cancer caused by ras oncogene. Methods for assaying products of oncogenes using the described peptides and antibodies are also disclosed. Method for treating cancer caused by ras oncogenes is also disclosed. Prefered peptides are (Thr)-Met-Arg-Thr-Arg-Val-Val-Ser-Gly-Phe-Val-Phe-Lev-Arg-Lev-Ile-Cgs.
Patent AU-765719-B2 (AU)
Title: Extracellular novel rage binding protein (EN-RAGE) and uses thereof
Inventor: SCHMIDT ANN MARIE
IPC: C07K14/705
Filed: 1999-10-06
Granted: 2003-09-25
Abstract: The present invention provides for an isolated human EN-RAGE peptide. The present invention also provides for a method for determining whether a compound is capable of inhibiting the interaction of an EN-RAGE peptide with a RAGE peptide, which comprises: (a) admixing: (i) a RAGE peptide or an sRAGE peptide or a fragment of either thereof, (ii) an EN-RAGE peptide or a fragment thereof, and (iii) the compound; (b) measuring the level of interaction between the peptide of step (a) (i) and the peptide of step (a) (ii), and (c) comparing the amount of interaction measured in step (b) with the amount measured between the petpide of step (a)(i) and the peptide of step (a) (ii) in the absence of the compound, thereby determining whether the compound is capable of inhibiting the interaction of the EN-RAGE peptide with the RAGE peptide, wherein a reduction in the amount of interaction in the presence of the compound indicates that the compound is capable of inhibiting the interaction. The present invention also provides for a method for inhibiting inflammation in a subject which comprises administering to the subject a compound capable of interfering with the interaction between EN-RAGE peptide and receptor for advanced glycation endproduct (RAGE) in the subject thereby inhibiting inflammation in the subject.
Patent AU-723078-B2 (AU)
Title: Procedure and apparatus for installing the overspeed governor of an elevator
Inventor: PETTERSSON HAKAN
IPC: B66B11/00
Filed: 1998-03-06
Granted: 2000-08-17
Abstract: PCT No. PCT/FI98/00206 Sec. 371 Date Jan. 6, 1999 Sec. 102(e) Date Jan. 6, 1999 PCT Filed Mar. 6, 1998 PCT Pub. No. WO98/40304 PCT Pub. Date Sep. 17, 1998The invention relates to a procedure and an apparatus intended to be used in elevator installation to install the overspeed governor (28) for the time it takes to install the elevator. According to the invention, when the elevator is being installed, at least one suspension element (17) is fastened to the upper part of the elevator shaft (2), an element (30) supporting the overspeed governor (28) is fitted to the suspension element and the position of the overspeed governor (28) at least in the vertical direction is so adjusted that it corresponds to the final placement of the overspeed governor (28). After the elevator guide rails (56) have been installed, the overspeed governor is removed from the suspension element (17) and fixed to a guide rail.
Patent AU-708870-B2 (AU)
Title: Gene therapy using ovine adenoviral vectors
Inventor: BOTH GERALD WAYNE
IPC: A61K35/76
Filed: 1996-08-14
Granted: 1999-08-12
Abstract: PCT No. PCT/AU96/00518 Sec. 371 Date Apr. 20, 1998 Sec. 102(e) Date Apr. 20, 1998 PCT Filed Aug. 14, 1996 PCT Pub. No. WO97/06826 PCT Pub. Date Feb. 27, 1997A method of delivering a nucleic acid molecule to a human cell which involves exposing to the cell a viral vector containing a DNA molecule including a nucleic acid sequence encoding the genome of an ovine adenovirus capable of infecting human cells or functionally equivalent nucleic acid sequence or portion thereof and at least one nucleic acid sequence encoding a gene to be expressed in the cell, such that the vector infects the cell and the infected cell expresses the gene.
Patent AU-751760-B2 (AU)
Title: Antigenic fusionprotein carrying galalpha1,3Gal epitopes
Inventor: HOLGERSSON JAN
IPC: A61P37/06
Filed: 1998-03-26
Granted: 2002-08-29
Abstract: A method for removing an antibody from blood or plasma, said method comprising contacting said blood or plasma with a fusion polypeptide, said fusion polypeptide comprising a first polypeptide operably linked to a second polypeptide, which first polypeptide comprises a part of a P-selectin glycoprotein ligand-1 that mediates binding to selectin and is glycosylated by an ± 1,3 galactosyltransferase, and which second polypeptide comprises an immunoglobulin polypeptide; and thereafter removing the complex from said blood or plasma, thereby removing the antibody from said blood or plasma.
Patent AU-599980-B2 (AU)
Title: Improved non-return valve and method for manufacturing same
Inventor: ROGER JENSEN OLE
IPC: A61F5/44
Filed: 1987-05-25
Granted: 1990-08-02
Abstract: A urine collection receptacle has a body formed by walls sealed along the periphery. First and second sheets form a drape which is situated between the walls. The drape extends across the body below the inlet, with the side edges of the drape sealed along opposing sections of the periphery. The sheets are sealed to each other along spaced vertical lines to define the body of a flap valve. The vertical sealed lines are severed to detach the flap valve body from the remainder of the drape. The sheets may also be sealed along oppositely oriented, downwardly inclined lines to form a funnel to direct liquid from the inlet toward the flap valve. The structure facilitates manufacture because the drape is sealed to the receptacle body in the same automated operation which seals the periphery of the walls.
Patent AU-636029-B2 (AU)
Title: Cosmetic composition
IPC: A61Q5/00
Filed: 1991-05-07
Granted: 1993-04-08
Abstract: A composition for topical application to human skin to provide protection from excessive exposure to ultra-violet rays, comprises an effective amount of a sunscreen comprising water-dispersible ultrafine titanium dioxide and oil-dispersible ultrafine titanium dioxide, together with a cosmetically acceptable vehicle for the sunscreen.
Patent AU-600500-B2 (AU)
Title: System for automatically inspecting a flat workpiece for holes
Inventor: WILKINSON BLAIR E
IPC: G01B11/14
Filed: 1987-08-05
Granted: 1990-08-16
Abstract: An inspection system is described for automatically documenting and verifying the position and dimensions of holes in a flat sheet metal workpiece (50). The system includes a transparent, light diffusing inspection table (l) upon which the workpiece is laid. A ball screw-driven yoke (6) travels continuously along the inspection table in the Y direction and includes a bottom bar for positioning a source of illumination (l4) below the table and a top bar for positioning a plurality of optical sensor arrays (30, 32) above the table. A detector is interconnected to the sensor arrays to detect light-to-dark and dark-to-light transitions which are representative of the edge of a hole. Circuitry is provided to multiplex the optical sensor arrays so that each pixel thereof is sequentially read in order to provide data corresponding to hole locations in the X direction across the table. The position of the yoke along the ball screw (2) provides data corresponding to hole locations in the Y direction.
Patent AU-544063-B2 (AU)
Title: Regenerating ion-exchange materials
Inventor: MARTINOLA FRIEDRICH
IPC: B01J49/90
Filed: 1981-10-29
Granted: 1985-05-16
Abstract: The invention concerns a counter-current adsorption filter for the treatment of liquids, with different adsorbents which require different regenerating agents, in which loading of the different adsorbents is effected in a stream of liquid flowing upwards and regeneration of the different loaded adsorbents with the different regenerating agents is effected in a stream of liquid flowing downwards, the inside of which filter is subdivided, by horizontal devices which are permeable to liquid, into a number of chambers corresponding to the number of different adsorbents to be used; in which the adsorbents which are regenerated with different regenerating agents are present in adjacent chambers; the chambers - with the exception of the topmost chamber of the filter - are equipped with a liquid drainage system which is located below the device which is permeable to liquid and forms the upper boundary of the chamber, and which is embedded in a layer of inert material; and in which the individual chambers are filled with a certain amount of adsorbent. The invention furthermore concerns a process for the operation of this letter.
Patent AU-649447-B2 (AU)
Title: Production of enzymes in seeds and their use
Inventor: PEN JAN
IPC: A23L25/00
Filed: 1991-03-25
Granted: 1994-05-26
Abstract: A method of catalyzing in vitro reactions using seeds containing enhanced amounts of enzymes is disclosed. The method involves adding transgenic, non-wild type seeds, preferably in a ground form, to a reaction mixture and allowing the enzymes in the seeds to increase the rate of reaction. By directly adding the seeds to the reaction mixture the method provides a solution to the expensive and problematic process of extracting and purifying the enzyme. Methods of treatment are also provided whereby a subject lacking a sufficient supply of an enzyme is administered the enzyme in the form of seeds containing enhanced amounts of the enzyme.
Patent AU-600970-B2 (AU)
Title: 23-deoxy derivatives of LL-F28249 compounds
Inventor: ASATO GORO
IPC: A01N43/90
Filed: 1987-09-11
Granted: 1990-08-30
Abstract: The present invention relates to novel derivatives of LL-F28249 compounds. These LL-F28249 compounds preferably are derived via a controlled microbiological fermentation of Streptomyces cyaneogriseus subsp. noncyanogenus having deposit accession number NRRL 15773. The 23-deoxy derivatives have the 23-hydroxy group replaced by hydrogen. The novel derivatives of the present invention possess activity as anthelmintic, ectoparasitic, insecticidal, acaricidal and nematicidal agents. They also are useful in areas of human and animal health and in agricultural crops.
Patent AU-647481-B2 (AU)
Title: Hexahydroazepine derivatives, a process for their preparation and pharmaceutical compositions containing them
Inventor: LAVASTRE SERGE
IPC: C07D295/088
Filed: 1991-06-14
Granted: 1994-03-24
Abstract: The invention relates to hexahydroazepine derivatives of formula: <IMAGE>  in which:   - A is a group chosen from the following: -CO-CH2-; -CH(OH)- CH2-: -CH2-CH2-; -CH=CH-; -C IDENTICAL C-;   - X represents hydrogen or a halogen;   - Y is a cyclohexyl group or, when X is hydrogen, a phenyl group; as well as their salts with inorganic or organic acids.
Patent AU-630817-B2 (AU)
Title: Polyisobutylene adhesives for transdermal devices
Inventor: WANG KARLY S
IPC: A61L15/58
Filed: 1991-04-12
Granted: 1992-11-05
Abstract: An in-line adhesive, useful for transdermal delivery devices comprising a mixture of high and low molecular weighted polyisobutylene having a ratio HMW PIB:LMW PIB in the range of about 5-40:95-60 which is substantially free of plasticizers and tackifiers is disclosed. The adhesive finds particular use as a component of a transdermal delivery device for delivering oily non-polar agents such as nicotine, benztropine, secoverine, dexsecoverine, and arecoline.
Patent AU-683697-B2 (AU)
Title: Carbostyril derivative for inhibiting production of interleukin-8
Inventor: MATSUDA TAKAHIDE
IPC: C07D215/22
Filed: 1994-10-17
Granted: 1997-11-20
Abstract: PCT No. PCT/JP94/01739 Sec. 371 Date Jun. 7, 1995 Sec. 102(e) Date Jun. 7, 1995 PCT Filed Oct. 17, 1994 PCT Pub. No. WO95/11026 PCT Pub. Date Apr. 27, 1995The present invention provides agents for inhibiting production of interleukin-8 and for inhibiting granulocytes activation as well as novel method for curing inflamatory diseases. The agents for inhibiting production of interleukin-8, and for inhibiting granulocytes activation and for curing inflammatory diseases, which contains as an active ingredient, a carbostyril derivative represented by the general formula (I):    <IMAGE>  (I)  where R is as described in the specification.
Patent AU-689817-B2 (AU)
Title: Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof
Inventor: BRYANT HENRY UHLMAN
IPC: A61K47/48
Filed: 1994-12-08
Granted: 1998-04-09
Abstract: The present invention provides aqueous inclusion complexes of certain known benzothiophene compounds, particularly Raloxifene, and water soluble cyclodextrins. Also provided are pharmaceutical compositions of such inclusion complexes, and methods of using these complexes for inhibiting bone loss and reducing serum cholesterol in mammals.
Patent AU-561650-B2 (AU)
Title: 2-oxo-1-(((substituted sulfonyl)amino)-carbonyl)- azetidines
Inventor: BREUER HERMANN
IPC: C07D417/14
Filed: 1982-03-16
Granted: 1987-05-14
Abstract: Antibacterial activity is exhibited by  beta -lactams having a   -@-NH-SO2R substituent in the 1-position and an acylamino substituent in the 3-position wherein Z is oxygen or sulfur and R is alkyl, alkenyl, alkynyl, substituted alkyl, phenyl, substituted phenyl, a 5,6 or 7-membered heterocycle (Rc), phenylalkyl, (substituted-phenyl)alkyl, Rc-alkyl or -NRaRb wherein Ra and Rb are the same or different and each is hydrogen, alkyl, substituted alkyl, phenyl, substituted phenyl, phenylalkyl, (substituted phenyl)alkyl or one of Ra and Rb is hydrogen, alkyl, phenyl, substituted phenyl, phenylalkyl or (substituted phenyl)alkyl and the other is amino (-NH2), alkanoylamino, arylcarbonylamino, alkoxycarbonylamino, alkylsulfonylamino, alkylamino, dialkylamino, phenylamino, (substituted phenyl- amino, hydroxy, cyano (-C IDENTICAL N), alkoxy, phenyloxy, (substituted phenyl)oxy, phenylalkoxy, (substituted phenyl)alkoxy, Rc as defined, above Rc-alkyl, Rc-alkoxy, alkylsulfonyl, alkylmethyleneamino, (alkyl-CH=N-), phenylmethyleneamino or (substituted phenyl)methyleneamino.
Patent AU-604791-B2 (AU)
Title: Viral vector and recombinant DNA coding, in particular, for the p25 protein of the virus that is a causal agent of aids, infected cell culture, protein obtained, vaccine and antibodies obtained
Inventor: GIRARD MARC
IPC: A61K39/42
Filed: 1987-11-27
Granted: 1991-01-03
Abstract: Viral vector comprising at least:  - a part of the genome of a vector virus, - the complete gag gene or one of its subfragments, especially a gene coding for the p25 protein or a gene coding for the p18 protein of the HIV virus responsible for AIDS, - and the elements ensuring the expression of this protein in eukaryote cells in a culture.
Patent AU-735371-B2 (AU)
Title: Novel phytase
Inventor: KRETZ KEITH
IPC: A23L5/20
Filed: 1998-08-13
Granted: 2001-07-05
Abstract: The invention provides a purified phytate enzyme derived from  Escherichia coli  B. The enzyme has a molecular weight of about 47.1 kilodaltons and has phytase activity (SEQ ID NO:2). The enzyme can be produced from native or recombinant host cells and can be used to aid in the digestion of phytate where desired. In particular, the phytase of the present invention can be used in animal feed.
Patent AU-652201-B2 (AU)
Title: Highly absorbent and flexible cellulosic pulp fluff sheet
Inventor: MURJI ZULFIKAR
IPC: A61F13/53
Filed: 1991-12-31
Granted: 1994-08-18
Abstract: A highly absorbent and flexible calendered and perf-embossed cellulosic pulp fluff sheet for use in disposable absorbent products such as sanitary napkins, wound dressings, bandages, incontinence pads, disposable diapers and the like. The invention also extends to a method for manufacturing the highly absorbent and flexible pulp fluff sheet and its method of use in disposable absorbent products. <IMAGE>
Patent AU-748076-B2 (AU)
Title: Shock absorbing component for packaging
Inventor: SIMPSON EUGENE D
IPC: B65D81/05
Filed: 1998-09-24
Granted: 2002-05-30
Abstract: The present invention relates to a shock absorbing component for packaging an article and for protecting the article during shipping. The component is foldable (preferably from a single sheet) for enclosing the article therein. The component comprises a first section for receiving a first surface of the article and a second section for receiving a second surface of the article. The first section having multiple nonlinear cuts or serrations such that upon placing the article between the first and second sections, the cuts allow the first section to deform and at least partially conform to the shape of the first surface of the article. The component may be disposed within and integrally formed with a shipping container having exterior protective walls. The component may further comprise spacer panels to separate the component from the exterior walls of the shipping container. Although the disclosed shipping container may have open ends, it desirably has ends completing the enclosure.
Patent AU-742846-B2 (AU)
Title: Particles
Inventor: CLARKE DAVID JOHN
IPC: A61K9/127
Filed: 1998-10-14
Granted: 2002-01-17
Abstract: Lipid vesicle particles capable of being targeted to a cell type of interest, said particle incorporating a peptide which is responsive to a predetermined metabolic signal from the targeted cell so as to modulate the permeability of the particle, said particle further incorporating a species to be targeted to the cell which is activated on said modulation of permeability. The particles may be used in methods for detecting cells, methods of treating cells and also therapeutically.
Patent AU-744429-B2 (AU)
Title: Computer generated multi-web moisture proof identification bracelet
Inventor: RILEY JAMES M
IPC: G09F3/00
Filed: 1998-10-06
Granted: 2002-02-21
Abstract: A multi-layer, multi-web, laser printable, page-sized form with an identification band blank comprises a multi-layered web die cut with a first paper label portion for receiving a printed image and an adhesive backed transparent film layer approximately twice the width of the paper layer so that upon separation from a carrier, the transparent film may be folded over and completely encapsulate the paper layer to moisture proof it and protect it. The transparent film layer includes a pair of adhesive backed tabs at the ends to facilitate its attachment about a patient's wrist or ankle. The band blank web is joined to a second multi-layer web with an overlapping glued joint, the second multi-layer web having a plurality of adhesive backed labels die cut into it.